Free Trial

LifeMD (LFMD) Competitors

LifeMD logo
$6.06 +0.24 (+4.12%)
As of 04/24/2025 04:00 PM Eastern

LFMD vs. CDNA, GRAL, PNTG, AVAH, CSTL, FLGT, AUNA, FTRE, TALK, and SBC

Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include CareDx (CDNA), Grail (GRAL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Auna (AUNA), Fortrea (FTRE), Talkspace (TALK), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry.

LifeMD vs.

LifeMD (NASDAQ:LFMD) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

LifeMD presently has a consensus price target of $11.00, indicating a potential upside of 81.52%. CareDx has a consensus price target of $30.33, indicating a potential upside of 64.05%. Given LifeMD's stronger consensus rating and higher possible upside, equities research analysts plainly believe LifeMD is more favorable than CareDx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.00
CareDx
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57

LifeMD has a beta of 2.22, suggesting that its stock price is 122% more volatile than the S&P 500. Comparatively, CareDx has a beta of 2.18, suggesting that its stock price is 118% more volatile than the S&P 500.

CareDx received 404 more outperform votes than LifeMD when rated by MarketBeat users. However, 76.47% of users gave LifeMD an outperform vote while only 65.92% of users gave CareDx an outperform vote.

CompanyUnderperformOutperform
LifeMDOutperform Votes
39
76.47%
Underperform Votes
12
23.53%
CareDxOutperform Votes
443
65.92%
Underperform Votes
229
34.08%

LifeMD has higher earnings, but lower revenue than CareDx. LifeMD is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$212.45M1.27-$20.60M-$0.54-11.22
CareDx$333.79M3.07-$190.28M$1.0218.13

LifeMD has a net margin of -12.06% compared to CareDx's net margin of -45.90%. LifeMD's return on equity of 0.00% beat CareDx's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD-12.06% N/A -36.34%
CareDx -45.90%-53.70%-30.42%

35.5% of LifeMD shares are owned by institutional investors. 16.0% of LifeMD shares are owned by insiders. Comparatively, 4.9% of CareDx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, CareDx had 6 more articles in the media than LifeMD. MarketBeat recorded 6 mentions for CareDx and 0 mentions for LifeMD. CareDx's average media sentiment score of 0.93 beat LifeMD's score of 0.53 indicating that CareDx is being referred to more favorably in the news media.

Company Overall Sentiment
LifeMD Positive
CareDx Positive

Summary

LifeMD beats CareDx on 10 of the 18 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMD vs. The Competition

MetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$270.18M$1.01B$5.41B$7.70B
Dividend YieldN/AN/A5.44%4.33%
P/E Ratio-9.4713.7122.1818.31
Price / Sales1.271.10397.31107.09
Price / CashN/A36.0138.2034.62
Price / Book40.409.196.834.25
Net Income-$20.60M-$52.07M$3.20B$247.51M
7 Day Performance11.60%9.73%5.79%6.08%
1 Month Performance-0.66%9.81%-5.53%-3.77%
1 Year Performance-45.70%6.50%16.85%4.60%

LifeMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
2.1779 of 5 stars
$6.06
+4.1%
$11.00
+81.5%
-45.7%$270.18M$212.45M-9.47230
CDNA
CareDx
3.7539 of 5 stars
$16.94
-3.9%
$30.33
+79.1%
+131.7%$938.92M$333.79M-6.27740Upcoming Earnings
News Coverage
Positive News
Gap Up
GRAL
Grail
0.6976 of 5 stars
$26.42
-2.1%
$26.00
-1.6%
N/A$932.55M$125.60M0.001,360Gap Up
PNTG
The Pennant Group
3.2841 of 5 stars
$24.50
-6.2%
$34.80
+42.0%
+23.4%$850.69M$695.24M36.035,340Positive News
AVAH
Aveanna Healthcare
1.181 of 5 stars
$4.22
-7.0%
$5.00
+18.5%
+96.5%$823.30M$2.02B-12.4133,000Gap Up
CSTL
Castle Biosciences
2.6455 of 5 stars
$21.14
-1.7%
$38.75
+83.3%
+5.4%$609.78M$332.07M105.71540Upcoming Earnings
FLGT
Fulgent Genetics
3.1522 of 5 stars
$17.92
+0.3%
$16.00
-10.7%
-8.2%$553.12M$283.47M-3.251,010Upcoming Earnings
Positive News
AUNA
Auna
3.5261 of 5 stars
$6.69
-3.9%
$13.05
+95.1%
-7.9%$494.86M$4.39B17.6114,958Gap Down
FTRE
Fortrea
3.7911 of 5 stars
$5.20
-1.7%
$16.70
+221.2%
-84.3%$469.04M$2.70B-1.5218,000
TALK
Talkspace
3.9931 of 5 stars
$2.58
-3.4%
$4.50
+74.4%
+1.6%$434.57M$187.59M258.26500Positive News
SBC
SBC Medical Group
N/A$4.11
+2.2%
N/AN/A$425.84M$205.42M0.00N/AGap Up

Related Companies and Tools


This page (NASDAQ:LFMD) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners